Vlad Ratziu (V Ratziu)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Venues

Hepatology (Baltimore, Md.)

Nature medicine

Nature communications

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Vlad Ratziu, Yusuf Yilmaz, Don Lazas, Scott L Friedman, Caroline Lackner, Cynthia Behling, Oscar W Cummings, Li Chen, Mathieu Petitjean, Yossi Gilgun-Sherki, Tali Gorfine, Shaul Kadosh, Eli Eyal, Arun J Sanyal
Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology (Baltimore, Md.) (2024)
Philip Noel Newsome, Arun J Sanyal, Guy Neff, Jörn Markus Schattenberg, Vlad Ratziu, Judith Ertle, Jasmin Link, Alison Mackie, Corinna Schoelch, Eric Lawitz, null null
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis. Nature communications 14 (1) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Olivier Govaere, Megan S R Hasoon, Leigh Alexander, Simon J Cockell, Dina Tiniakos, Mattias Ekstedt, Jörn Markus Schattenberg, Jerome Boursier, Elisabetta Bugianesi, Vlad Ratziu, null null, Ann K Daly, Quentin Mark Anstee
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nature metabolism (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Vlad Ratziu, Sven Francque, Cynthia A Behling, Vanja Cejvanovic, Helena Cortez-Pinto, Janani S Iyer, Niels Krarup, Quang Le, Anne-Sophie Sejling, Dina Tiniakos, Stephen A Harrison
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) (2023)
Vlad Ratziu
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Vlad Ratziu
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Marta B Afonso, Tawhidul Islam, Julie Magusto, Ricardo Amorim, Véronique Lenoir, Rui F Simões, José Teixeira, Liana C Silva, Dominique Wendum, Isabelle Jéru, Corinne Vigouroux, Rui E Castro, Paulo J Oliveira, Carina Prip-Buus, Vlad Ratziu, Jérémie Gautheron, Cecília Maria Pereira Rodrigues
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Hepatology (Baltimore, Md.) (2022)
Vlad Ratziu, Quentin Mark Anstee, Vincent Wai-Sun Wong, Jörn Markus Schattenberg, Elisabetta Bugianesi, Salvador Augustin, Liana Gheorghe, Vittoria Zambon, Nancy S Reau
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. Hepatology (Baltimore, Md.) 76 (6) (2022)
Lin Lei, Alix Bruneau, Haquima El Mourabit, Justine Guégan, Trine Folseraas, Sara Lemoinne, Tom Hemming Karlsen, Bénédicte Hoareau, Romain Morichon, Ester Gonzalez-Sanchez, Claire Goumard, Vlad Ratziu, Pierre Charbord, Jérémie Gautheron, Frank Tacke, Thierry Jaffredo, Axelle Cadoret, Chantal Housset
Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology (Baltimore, Md.) 76 (5) (2022)
Vlad Ratziu, L de Guevara, R Safadi, F Poordad, F Fuster, J Flores-Figueroa, M Arrese, Anna L Fracanzani, D Ben Bashat, K Lackner, T Gorfine, S Kadosh, R Oren, M Halperin, L Hayardeny, Stephen Caldwell, Scott L Friedman, null null, Arun J Sanyal
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nature medicine 27 (10) (2021)

Vlad Ratziu.css-eqlu8i{font-size:small;padding-left:4px;} (V Ratziu)

Publication Activity (10 Years)

Top Topics

Top Venues

Vlad Ratziu (V Ratziu)